These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 27729738)

  • 21. Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy.
    Wong GL; Wong VW
    World J Gastroenterol; 2013 Oct; 19(39):6515-22. PubMed ID: 24151375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verification of hepatitis B-related hepatocellular carcinoma predictive models to evaluate the risk of HCC in patients with liver cirrhosis under antiviral treatment.
    Huang X; Wang H; Zhang W; Gu E
    Eur J Gastroenterol Hepatol; 2022 May; 34(5):546-552. PubMed ID: 35170528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
    Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
    J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection.
    Abu-Amara M; Cerocchi O; Malhi G; Sharma S; Yim C; Shah H; Wong DK; Janssen HL; Feld JJ
    Gut; 2016 Aug; 65(8):1347-58. PubMed ID: 25934760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis.
    Shin SH; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Kim BK
    Liver Int; 2015 Mar; 35(3):1054-62. PubMed ID: 24930484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG; Mohammed R; Yuen MF; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B.
    Sohn W; Cho JY; Kim JH; Lee JI; Kim HJ; Woo MA; Jung SH; Paik YH
    Clin Mol Hepatol; 2017 Jun; 23(2):170-178. PubMed ID: 28506056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment.
    Wong GL; Chan HL; Chan HY; Tse PC; Tse YK; Mak CW; Lee SK; Ip ZM; Lam AT; Iu HW; Leung JM; Wong VW
    Gastroenterology; 2013 May; 144(5):933-44. PubMed ID: 23415803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection.
    Yu JH; Cho SG; Jin YJ; Lee JW
    Clin Mol Hepatol; 2022 Jul; 28(3):351-361. PubMed ID: 34823308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
    Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ
    Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
    Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
    Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
    J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B.
    Shin H; Jung YW; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Kim YY; Choi JY; Kim SU
    Clin Mol Hepatol; 2019 Dec; 25(4):390-399. PubMed ID: 31146508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus splicing is enhanced prior to development of hepatocellular carcinoma.
    Bayliss J; Lim L; Thompson AJ; Desmond P; Angus P; Locarnini S; Revill PA
    J Hepatol; 2013 Nov; 59(5):1022-8. PubMed ID: 23811301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepatitis B virus (HBV) mutation in enhancer I (HBV Enh I)/X-promoter and the relationship between chronic HBV-related disease spectrum].
    Deng HH; Guan YJ; Lei CL; Xu M; Hu FY; Cheng J; Li YP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):25-7. PubMed ID: 22919746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
    Lin CL; Kao JH
    J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
    Kim WR; Loomba R; Berg T; Aguilar Schall RE; Yee LJ; Dinh PV; Flaherty JF; Martins EB; Therneau TM; Jacobson I; Fung S; Gurel S; Buti M; Marcellin P
    Cancer; 2015 Oct; 121(20):3631-8. PubMed ID: 26177866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B.
    Liang LY; Lee HW; Wong VW; Yip TC; Tse YK; Hui VW; Lui GC; Chan HL; Wong GL
    Clin Mol Hepatol; 2021 Jul; 27(3):499-509. PubMed ID: 33631920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.